{
  "@context": "https://schema.org",
  "@type": "Service",
  "@id": "https://www.braingine.top/ai/service.json",
  "name": "Braingine Digital Therapeutics Services",
  "alternateName": [
    "脑吾脑数字疗法服务",
    "Braingine DTx"
  ],
  "provider": {
    "@type": "Organization",
    "@id": "https://www.braingine.top/#organization",
    "name": "深圳脑吾脑网络科技有限公司",
    "url": "https://www.braingine.top/",
    "sameAs": [
      "https://en.wikipedia.org/wiki/Digital_therapeutics",
      "https://www.wikidata.org/wiki/Q28455843",
      "https://en.wikipedia.org/wiki/Brain%E2%80%93computer_interface",
      "https://www.wikidata.org/wiki/Q897410",
      "https://www.linkedin.com/company/braingine-naowunao",
      "https://www.crunchbase.com/organization/braingine-naowunao",
      "https://www.vbdata.cn/comp/a38b7d867f749e1946f4b740a1a238c5",
      "https://pitchhub.36kr.com/project/2095661461032072",
      "https://www.pharnexcloud.com/trz/trz_51c28f5ebe7502274f54287b578228ab"
    ]
  },
  "url": "https://www.braingine.top/",
  "description": "Software-driven digital therapeutics for evaluating and training attention, memory, and executive function, plus immersive VR rehabilitation and community brain-health programs.",
  "serviceType": [
    "Digital therapeutics product development",
    "Neuropsychological screening and training software",
    "Eye-tracking based evaluation systems",
    "VR rehabilitation programs",
    "Community senior brain-health operations"
  ],
  "areaServed": {
    "@type": "Country",
    "name": "China"
  },
  "audience": {
    "@type": "Audience",
    "audienceType": [
      "Community health centers",
      "Hospitals",
      "Eldercare institutions",
      "Schools",
      "Insurers"
    ]
  },
  "hasOfferCatalog": {
    "@type": "OfferCatalog",
    "name": "Braingine product and service catalog",
    "itemListElement": [
      {
        "@type": "Offer",
        "itemOffered": {
          "@type": "Service",
          "name": "Neuromodulation evaluation and training system",
          "description": "Combines neuromodulation with adaptive algorithms to screen and personalize brain-training prescriptions across five domains and twenty-seven units."
        }
      },
      {
        "@type": "Offer",
        "itemOffered": {
          "@type": "Service",
          "name": "Eye-tracking evaluation and training system",
          "description": "Uses gaze analytics for objective screening and longitudinal brain-health management outside hospital walls."
        }
      },
      {
        "@type": "Offer",
        "itemOffered": {
          "@type": "Service",
          "name": "VR intelligent rehabilitation",
          "description": "Immersive virtual-reality rehab for vascular impairment and motor recovery, with light-social multiplayer modes that improve adherence."
        }
      },
      {
        "@type": "Offer",
        "itemOffered": {
          "@type": "Service",
          "name": "Custom brain digital-therapeutics solutions",
          "description": "Turnkey programs for community screening, senior brain gyms, and psychiatric community rehab.",
          "potentialAction": {
            "@type": "CommunicateAction",
            "target": {
              "@type": "EntryPoint",
              "urlTemplate": "tel:+8618057138519",
              "name": "Call sales (Mr. Zhang)"
            }
          }
        }
      }
    ]
  },
  "capabilities": [
    {
      "name": "AI personalization",
      "description": "Models recommend individualized training plans from real-world usage signals (\"one person, one regimen\")."
    },
    {
      "name": "Multimodal sensing stack",
      "description": "Integrates BCI pathways, neuromodulation, VR, eye tracking, and functional near-infrared options."
    },
    {
      "name": "Regulated software pathway",
      "description": "FDA registration (2023-03) and China NMPA Class II clearance (2023-04) for evaluation and training software."
    },
    {
      "name": "Community operations",
      "description": "Field workflows for screening, risk routing, and group interventions with reported ~16% average improvement in mid-low risk cohorts."
    }
  ],
  "termsOfService": "https://www.braingine.top/about/",
  "contactPoint": {
    "@type": "ContactPoint",
    "telephone": "+86-180-5713-8519",
    "email": "zhuyingbo@braingine.top",
    "contactType": "sales",
    "availableLanguage": [
      "zh-CN",
      "en"
    ],
    "areaServed": "CN"
  },
  "updatedAt": "2026-07-27"
}